FIELD: medicine; pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to ophthalmology. Disclosed is use of composition containing 0.05 to 1 wt./wt.% pimecrolimus, for the treatment of subjects with a clinical diagnosis of moderate to severe blepharitis, where the subjects to be treated have moderate to severe blepharitis signs and symptoms, characterized by the presence of eyelid oedema, debris and eye discomfort.
EFFECT: invention provides creating an ophthalmic composition well tolerated by patients and used in therapy of moderate to severe blepharitis.
30 cl, 10 dwg, 11 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF EYE DISEASES | 2020 |
|
RU2827551C2 |
| METHOD FOR EVALUATION OF EFFICIENCY OF TREATMENT OF CHRONIC BLEPHARITIS BY LASER DOPPLER FLOWMETRY | 2017 |
|
RU2644699C1 |
| GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
| METHOD OF "DRY EYE" SYNDROME TREATMENT | 2014 |
|
RU2546922C1 |
| OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCULAR SURFACE DAMAGE AND DRY EYE SYMPTOMS | 2019 |
|
RU2806212C2 |
| METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
| JELLY PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECTIC BLEPHARITIS AND BLEPHAROCONJUNCTIVITIS | 2013 |
|
RU2533274C1 |
| COMPOSITION FOR EFFECTIVE LIPID DELIVERY TO HUMAN TEAR FILM USING SALT-SENSITIVE EMULSION SYSTEM | 2012 |
|
RU2772357C2 |
| COMPOSITION FOR HYGIENIC TREATMENT OF THE EYELIDS | 2021 |
|
RU2778503C1 |
| OPHTHALMIC COMPOSITIONS FOR TREATING DRY EYE SYNDROME | 2019 |
|
RU2828769C2 |
